Rapport Therapeutics, Inc. ($RAPP)
Bredt David โ Chief Scientific Officer
Shares
18,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Bredt David |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Dec 31, 2025 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 5, 2026 |
| Shares Purchased | 18,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 410,642 |
| Derivative | No |
| Accession Number | 0001193125-26-002470 |
| Document | View SEC Filing |